Pharmacyclics

Pharmacyclics is a biopharmaceutical company focused on developing targeted cancer therapies, especially for blood cancers like leukemia and lymphoma. They identify and create drugs that specifically block the growth of cancer cells while sparing healthy cells, aiming to improve treatment effectiveness and reduce side effects. Their notable product, ibrutinib (brand name Imbruvica), is an oral medication that has revolutionized treatment options for certain blood cancers. The company's work involves research, development, and collaboration with healthcare providers to bring innovative, science-driven therapies to patients.